227 related articles for article (PubMed ID: 15203165)
1. Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
Sun LQ; Chen J; Bruce M; Deskus JA; Epperson JR; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
Bioorg Med Chem Lett; 2004 Jul; 14(14):3799-802. PubMed ID: 15203165
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.
Sun LQ; Chen J; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
Bioorg Med Chem Lett; 2004 Mar; 14(5):1197-200. PubMed ID: 14980664
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 3-phenyltetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands. Part II.
Durieux S; Chanu A; Bochu C; Audinot V; Coumailleau S; Boutin JA; Delagrange P; Caignard DH; Bennejean C; Renard P; Lesieur D; Berthelot P; Yous S
Bioorg Med Chem; 2009 Apr; 17(8):2963-74. PubMed ID: 19329323
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and melatoninergic activity of new azido- and isothiocyanato-substituted indoles.
Tsotinis A; Afroudakis PA; Davidson K; Prashar A; Sugden D
J Med Chem; 2007 Dec; 50(25):6436-40. PubMed ID: 17988084
[TBL] [Abstract][Full Text] [Related]
6. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-affinity-activity relationships of novel benzofuran derivatives as MT(2) melatonin receptor selective ligands.
Wallez V; Durieux-Poissonnier S; Chavatte P; Boutin JA; Audinot V; Nicolas JP; Bennejean C; Delagrange P; Renard P; Lesieur D
J Med Chem; 2002 Jun; 45(13):2788-800. PubMed ID: 12061881
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2-amido-2,3-dihydro-1H-phenalene derivatives as new conformationally restricted ligands for melatonin receptors.
Mathé-Allainmat M; Gaudy F; Sicsic S; Dangy-Caye AL; Shen S; Brémont B; Benatalah Z; Langlois M; Renard P; Delagrange P
J Med Chem; 1996 Aug; 39(16):3089-95. PubMed ID: 8759629
[TBL] [Abstract][Full Text] [Related]
10. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.
Mor M; Rivara S; Silva C; Bordi F; Plazzi PV; Spadoni G; Diamantini G; Balsamini C; Tarzia G; Fraschini F; Lucini V; Nonno R; Stankov BM
J Med Chem; 1998 Sep; 41(20):3831-44. PubMed ID: 9748358
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of naphthalenic derivatives as new ligands at the melatonin binding site MT3.
Leclerc V; Ettaoussi M; Rami M; Farce A; Boutin JA; Delagrange P; Caignard DH; Renard P; Berthelot P; Yous S
Eur J Med Chem; 2011 May; 46(5):1622-9. PubMed ID: 21377769
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
Ettaoussi M; Péres B; Klupsch F; Delagrange P; Boutin JA; Renard P; Caignard DH; Chavatte P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 May; 16(9):4954-62. PubMed ID: 18372181
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.
Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A
J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685
[TBL] [Abstract][Full Text] [Related]
14. Chronobiotic activity of N-[2-(2,7-dimethoxyfluoren-9-yl)ethyl]-propanamide. Synthesis and melatonergic pharmacology of fluoren-9-ylethyl amides.
Epperson JR; Bruce MA; Catt JD; Deskus JA; Hodges DB; Karageorge GN; Keavy DJ; Mahle CD; Mattson RJ; Ortiz AA; Parker MF; Takaki KS; Watson BT; Joseph P Yevich
Bioorg Med Chem; 2004 Sep; 12(17):4601-11. PubMed ID: 15358287
[TBL] [Abstract][Full Text] [Related]
15. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
[TBL] [Abstract][Full Text] [Related]
16. New ligands at the melatonin binding site MT(3).
Boussard MF; Truche S; Rousseau-Rojas A; Briss S; Descamps S; Droual M; Wierzbicki M; Ferry G; Audinot V; Delagrange P; Boutin JA
Eur J Med Chem; 2006 Mar; 41(3):306-20. PubMed ID: 16414149
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of potent N1-substituted indole melatonin receptor agonists.
Tsotinis A; Eleutheriades A; Hough K; Sugden D
Chem Commun (Camb); 2003 Feb; (3):382-3. PubMed ID: 12613623
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and pharmacological effects of structurally simple ligands for MT(1) and MT(2) melatonin receptors.
Carocci A; Catalano A; Lovece A; Lentini G; Duranti A; Lucini V; Pannacci M; Scaglione F; Franchini C
Bioorg Med Chem; 2010 Sep; 18(17):6496-511. PubMed ID: 20674373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
